5-HT2-RECEPTOR BLOCKADE IN THE TREATMENT OF HEART FAILURE-Reference-Cited by-同舟云学术

5-HT2-RECEPTOR BLOCKADE IN THE TREATMENT OF HEART FAILURE

Published:1981-05 Issue:8231 Volume:317 Page:1186-1188
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Demoulin Jean-Claude,Soumagne Daniel,Bertholet Michel,David Jean-Louis,Kulbertus HenriE

Publisher

Elsevier BV

Subject

General Medicine

Reference12 articles.

1. Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance;Cohn;Circulation,1973

2. Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure;Faxon;Circulation,1980

3. Serotonin and pulmonary hypertension m human septic ARDS;Sibbald;Critical Care Med,1980

4. The interaction of serotonin and noradrenaline of the perfused artery;de la Lande;Br J Pharmacol Chemother,1966

5. F. de Clerck, Jl David, Paj Janssen, Amplification by 5-hydroxytryptamine of platele activation. Inhibition by R 41 468, a specific 5 HT2-receptor antagonist ((unpublished)).

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serotonin paracrine signaling in tissue fibrosis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2013-07

2. Ketanserin;Cardiovascular Drug Reviews;2007-04-02

3. Ketanserin;xPharm: The Comprehensive Pharmacology Reference;2007

4. Serotonin: Ubiquitous Neuromodulator in the Failing Heart;Asian Cardiovascular and Thoracic Annals;1998-03

5. 5-HT2A receptor antagonists inhibit potassium-stimulated γ-aminobutyric acid release in rat frontal cortex;European Journal of Pharmacology;1996-08